Picture of GSK logo

GSK GSK News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareConservativeLarge CapNeutral

REG - GSK PLC - Notice of AGM

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250324:nRSX9321Ba&default-theme=true

RNS Number : 9321B  GSK PLC  24 March 2025

GSK plc

(the 'Company')

 

Publication of Notice of Annual General Meeting 2025

 

The Company has today published on its website
(www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/
(http://www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/)
) the Notice of Annual General Meeting ('AGM') 2025 (the '2025 AGM Notice'),
which will be distributed to shareholders shortly.

 

The Company's AGM will be held on Wednesday 7 May 2025 at 2.30pm at The
Landmark London, 222 Marylebone Road, London, NW1 6JQ and will also be
broadcast live for shareholders to join electronically. Full details of how to
join the meeting either in person or electronically are contained in the 2025
AGM Notice and AGM Guide.

In compliance with Listing Rule 6.4.1R of the UK Financial Conduct Authority's
('FCA') Listing Rules, the following documents  will be submitted to the FCA
and will, in due course, be available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) :

 

·      2025 AGM Notice

·      Proxy Form for the AGM

·      The rules of the GSK Share Value Plan

 

 

 

V A Whyte

Company Secretary

 

24 March 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOAJIMFTMTMTBBA

Recent news on GSK

See all news